134 related articles for article (PubMed ID: 38016189)
1. [Efficacy of intratympanic infiltration of N-acetyl cysteine in cisplatin ototoxicity].
Rosas-Gutiérrez GDC; Fernández-Hernández JP; Olea-González AI
Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S318-S322. PubMed ID: 38016189
[TBL] [Abstract][Full Text] [Related]
2. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
Saliba I; El Fata F; Ouelette V; Robitaille Y
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
[TBL] [Abstract][Full Text] [Related]
3. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
[TBL] [Abstract][Full Text] [Related]
4. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
Sarafraz Z; Ahmadi A; Daneshi A
Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
[TBL] [Abstract][Full Text] [Related]
5. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
6. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy.
Riga MG; Chelis L; Kakolyris S; Papadopoulos S; Stathakidou S; Chamalidou E; Xenidis N; Amarantidis K; Dimopoulos P; Danielides V
Am J Clin Oncol; 2013 Feb; 36(1):1-6. PubMed ID: 22134515
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone: A Randomized Controlled Study.
Marshak T; Steiner M; Kaminer M; Levy L; Shupak A
Otolaryngol Head Neck Surg; 2014 Jun; 150(6):983-90. PubMed ID: 24618499
[TBL] [Abstract][Full Text] [Related]
10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
11. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
12. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
Naples JG; Parham K
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):144-9. PubMed ID: 26419839
[TBL] [Abstract][Full Text] [Related]
14. Otologic safety of intratympanic N-acetylcysteine in an animal model.
Chan CY; Conley SF; Salameh S; Sayegh J; Wurzba SDS; Grenier K; Linn DT; Partain MP; Daniel SJ
Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111702. PubMed ID: 37696227
[TBL] [Abstract][Full Text] [Related]
15. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
Simsek G; Taş BM; Muluk NB; Azman M; Kılıç R
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
Yoo J; Hamilton SJ; Angel D; Fung K; Franklin J; Parnes LS; Lewis D; Venkatesan V; Winquist E
Laryngoscope; 2014 Mar; 124(3):E87-94. PubMed ID: 23946126
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear.
Gausterer JC; Saidov N; Ahmadi N; Zhu C; Wirth M; Reznicek G; Arnoldner C; Gabor F; Honeder C
Eur J Pharm Biopharm; 2020 May; 150():143-155. PubMed ID: 32173603
[TBL] [Abstract][Full Text] [Related]
19. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Protective Effect of N-Acetylcysteine against Amikacin-Induced Ototoxicity in End-Stage Renal Disease: A Randomized Trial.
Vural A; Koçyiğit İ; Şan F; Eroğlu E; Ketenci İ; Ünal A; Tokgöz B; Ünlü Y
Perit Dial Int; 2018; 38(1):57-62. PubMed ID: 29097487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
